1. Home
  2. EBON vs CVKD Comparison

EBON vs CVKD Comparison

Compare EBON & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBON
  • CVKD
  • Stock Information
  • Founded
  • EBON 2010
  • CVKD 2022
  • Country
  • EBON China
  • CVKD United States
  • Employees
  • EBON N/A
  • CVKD N/A
  • Industry
  • EBON Semiconductors
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • EBON Technology
  • CVKD Health Care
  • Exchange
  • EBON Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • EBON 25.3M
  • CVKD 29.5M
  • IPO Year
  • EBON 2020
  • CVKD 2023
  • Fundamental
  • Price
  • EBON $3.37
  • CVKD $12.68
  • Analyst Decision
  • EBON
  • CVKD Strong Buy
  • Analyst Count
  • EBON 0
  • CVKD 1
  • Target Price
  • EBON N/A
  • CVKD $32.00
  • AVG Volume (30 Days)
  • EBON 9.0K
  • CVKD 33.5K
  • Earning Date
  • EBON 08-22-2025
  • CVKD 08-06-2025
  • Dividend Yield
  • EBON N/A
  • CVKD N/A
  • EPS Growth
  • EBON N/A
  • CVKD N/A
  • EPS
  • EBON N/A
  • CVKD N/A
  • Revenue
  • EBON $5,868,771.00
  • CVKD N/A
  • Revenue This Year
  • EBON N/A
  • CVKD N/A
  • Revenue Next Year
  • EBON N/A
  • CVKD N/A
  • P/E Ratio
  • EBON N/A
  • CVKD N/A
  • Revenue Growth
  • EBON 20.88
  • CVKD N/A
  • 52 Week Low
  • EBON $3.00
  • CVKD $5.70
  • 52 Week High
  • EBON $10.94
  • CVKD $22.90
  • Technical
  • Relative Strength Index (RSI)
  • EBON 42.44
  • CVKD 47.47
  • Support Level
  • EBON $3.17
  • CVKD $11.00
  • Resistance Level
  • EBON $3.60
  • CVKD $13.24
  • Average True Range (ATR)
  • EBON 0.23
  • CVKD 1.13
  • MACD
  • EBON -0.00
  • CVKD 0.20
  • Stochastic Oscillator
  • EBON 31.59
  • CVKD 72.33

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: